Wellington Management Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,365,570
Closed -$7.18M 2400
2017
Q4
$7.18M Hold
1,365,570
﹤0.01% 1370
2017
Q3
$8.37M Buy
1,365,570
+52,474
+4% +$332K ﹤0.01% 1324
2017
Q2
$9.49M Buy
1,313,096
+50,693
+4% +$312K ﹤0.01% 1228
2017
Q1
$6.69M Sell
1,262,403
-16,906
-1% -$114K ﹤0.01% 1351
2016
Q4
$9.19M Buy
1,279,309
+111,486
+10% +$901K ﹤0.01% 1222
2016
Q3
$10.9M Buy
1,167,823
+17,324
+2% +$144K ﹤0.01% 1142
2016
Q2
$7.27M Buy
1,150,499
+53,197
+5% +$342K ﹤0.01% 1233
2016
Q1
$6.06M Sell
1,097,302
-1,365,795
-55% -$5.14M ﹤0.01% 1312
2015
Q4
$13.7M Sell
2,463,097
-1,888,496
-43% -$12.5M ﹤0.01% 1083
2015
Q3
$36.8M Buy
4,351,593
+1,830,644
+73% +$31M 0.01% 777
2015
Q2
$38.1M Sell
2,520,949
-882,465
-26% -$12.7M 0.01% 805
2015
Q1
$54.5M Sell
3,403,414
-265,874
-7% -$4.73M 0.01% 703
2014
Q4
$65.4M Sell
3,669,288
-81,147
-2% -$1.01M 0.02% 645
2014
Q3
$37.7M Buy
3,750,435
+1,611,700
+75% +$19.5M 0.01% 817
2014
Q2
$33.4M Buy
2,138,735
+857,400
+67% +$12.1M 0.01% 869
2014
Q1
$23.8M Buy
1,281,335
+826,550
+182% +$16.6M 0.01% 969
2013
Q4
$8.69M Buy
454,785
+3,000
+0.7% +$60.9K ﹤0.01% 1287
2013
Q3
$7.38M Sell
451,785
-597,605
-57% -$6.28M ﹤0.01% 1305
2013
Q2
$7.93M Buy
+1,049,390
New +$8.3M ﹤0.01% 1263

Other funds holding PETX

Wellington Management Group's PETX Position: Q1 2018 in Review

Wellington Management Group sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2018, closing a stake of 1,365,570 shares — an estimated $7.18M sold.

Wellington Management Group first reported a position in PETX in Q2 2013 and held it in 19 quarters. The position peaked at $65.4M in Q4 2014. 103 funds tracked by Wall St. Rank hold PETX as of Q1 2018.

  • Wellington Management Group reported no remaining Aratana Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Wellington Management Group sold 1,365,570 Aratana Therapeutics, Inc. shares in Q1 2018, an estimated $7.18M.
  • Wellington Management Group first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
  • Wellington Management Group's Aratana Therapeutics, Inc. position peaked at $65.4M in Q4 2014.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2018.

Based on Wellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.